Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients
Introduction: ESCRT is a molecular machine involved in various important physiological processes, such as the formation of multivesicular bodies, cellular autophagy, and cellular membrane repair. CHMP7 is a regulatory subunit of ESCRT-III and is necessary for the proper functioning of ESCRT. In this...
Main Authors: | Yu Guo, Shu Wang, Feng Liang, Min Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1211843/full |
Similar Items
-
CDK1 controls CHMP7-dependent nuclear envelope reformation
by: Alberto T Gatta, et al.
Published: (2021-07-01) -
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy
by: Hongtuan Zhang, et al.
Published: (2023-06-01) -
CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation
by: Kang Li, et al.
Published: (2015-12-01) -
CHMP4C: A novel regulator of the mitotic spindle checkpoint
by: Eleni Petsalaki, et al.
Published: (2018-05-01) -
The Role of Exosome and the ESCRT Pathway on Enveloped Virus Infection
by: Yichen Ju, et al.
Published: (2021-08-01)